Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
abandoned, accrual, adversely, Agencourt, aimed, Amgen, asset, begun, Bioscience, board, case, cautioned, CDAD, closing, Clostridium, committee, comparison, concentrate, Creighton, depreciation, detailed, diarrhea, directly, divested, divestiture, document, efficacy, ensure, evidence, evolution, experience, explore, extend, fairly, final, fiscal, fixed, force, formation, fourteen, fourth, fraud, goal, Helicobacter, impact, Impairment, important, intensified, inventory, January, Labaudiniere, larger, level, light, loan, longer, Martin, maximum, merged, offered, ongoing, outplacement, paragraph, percent, persuasive, physician, qualify, recent, Refer, repay, Restated, Retirement, revised, Richard, role, safety, satisfy, single, sponsored, statement, suitable, summarize, summarized, transfer, transferred, underlying, understanding, University, unsponsored, untrue, unusual, upfront, Vicuron, work, wrote, Yesx
Removed:
academic, active, April, automation, award, awarded, aware, bacterial, base, call, chronic, commencing, competing, decline, dilution, discretion, DNA, effectively, enhance, expiring, exposure, extent, finance, Flow, forward, generate, GenomeVision, governmental, harbor, industry, initiative, instrument, international, iv, judgment, jurisdiction, lease, liquidated, liquidity, marketing, mining, monthly, nationally, Network, NHGRI, nonexclusive, PathoGenome, pilot, policy, production, protein, range, reduced, remaining, renewing, resulted, safe, scope, security, software, specifically, stage, Supplemental, typically, update
Filing tables
Filing exhibits
OSCI similar filings
Filing view
External links
Exhibit 99.1
CERTIFICATION PURSUANT TO
SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, as President and Chief Executive Officer of Genome Therapeutics Corp. (the “Company”) does hereby certify that to my knowledge:
1) | the Company’s Report on Form 10-Q for the quarter ended March 29, 2003, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
2) | the information contained in the Company’s Report on Form 10-Q for the quarter ended March 29, 2003, fairly presents, in all material respects, the financial condition and results of operations of the Company. |
By: /s/ Steven M. Rauscher
Steven M. Rauscher
President & Chief Executive Officer
Dated: May 13, 2003